InnovAge Holding Corp. Increase (Decrease) in Accounts Receivable
InnovAge Holding Corp. (INNV) reported Increase (Decrease) in Accounts Receivable of $6.02 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-09-09
- InnovAge Holding Corp. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $13.81M.
- InnovAge Holding Corp. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $7.28M.
- InnovAge Holding Corp. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$1.87M, a 154.01% decline year-over-year.
- InnovAge Holding Corp. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$13.20M.
- InnovAge Holding Corp. increase (decrease) in accounts receivable for fiscal 2026 was $6.02M.
- InnovAge Holding Corp. increase (decrease) in accounts receivable for fiscal 2025 was -$11.21M, a 136.96% decline from fiscal 2024.
- InnovAge Holding Corp. increase (decrease) in accounts receivable for fiscal 2024 was $30.33M.
- InnovAge Holding Corp. increase (decrease) in accounts receivable for fiscal 2023 was -$8.22M, a 186.50% decline from fiscal 2022.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $21.09M derived: sum of 2 quarters · filed 2026-09-09 | $19.22M derived: sum of 3 quarters · filed 2026-09-09 | $6.02M 10-K · filed 2026-09-09 |
| 2026-03-31 | $7.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $5.41M derived: sum of 2 quarters · filed 2026-05-08 | -$7.79M 10-Q · filed 2026-05-08 | -$15.82M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | -$1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$15.07M 10-Q · filed 2026-02-03 | -$23.10M derived: sum of 3 quarters · filed 2026-09-09 | -$28.46M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | -$13.20M 10-Q · filed 2025-11-04 | -$21.23M derived: sum of 2 quarters · filed 2026-09-09 | -$26.59M derived: sum of 3 quarters · filed 2026-09-09 | -$23.12M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | -$8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$13.39M derived: sum of 2 quarters · filed 2026-09-09 | -$9.92M derived: sum of 3 quarters · filed 2026-09-09 | -$11.21M 10-K · filed 2026-09-09 |
| 2025-03-31 | -$5.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | -$1.89M derived: sum of 2 quarters · filed 2026-05-08 | -$3.18M 10-Q · filed 2026-05-08 | $10.35M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $3.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $2.18M 10-Q · filed 2026-02-03 | $15.71M derived: sum of 3 quarters · filed 2026-02-03 | $11.08M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$1.29M 10-Q · filed 2025-11-04 | $12.24M derived: sum of 2 quarters · filed 2025-11-04 | $7.61M derived: sum of 3 quarters · filed 2025-11-04 | $8.13M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $13.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $8.90M derived: sum of 2 quarters · filed 2025-09-09 | $9.41M derived: sum of 3 quarters · filed 2025-09-09 | $30.33M 10-K · filed 2025-09-09 |
| 2024-03-31 | -$4.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | -$4.12M derived: sum of 2 quarters · filed 2025-05-06 | $16.80M 10-Q · filed 2025-05-06 | $7.97M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $512.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | $21.43M 10-Q · filed 2025-02-04 | $12.60M derived: sum of 3 quarters · filed 2025-02-04 | $8.23M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | $20.92M 10-Q · filed 2024-11-05 | $12.09M derived: sum of 2 quarters · filed 2024-11-05 | $7.71M derived: sum of 3 quarters · filed 2024-11-05 | $9.52M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$8.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | -$13.20M derived: sum of 2 quarters · filed 2024-09-10 | -$11.40M derived: sum of 3 quarters · filed 2024-09-10 | -$8.22M 10-K · filed 2024-09-10 |
| 2023-03-31 | -$4.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | -$2.57M derived: sum of 2 quarters · filed 2024-05-07 | $609.00K 10-Q · filed 2024-05-07 | $5.96M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | $4.98M 10-Q · filed 2024-02-06 | $10.33M derived: sum of 3 quarters · filed 2024-02-06 | $10.90M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | $3.18M 10-Q · filed 2023-11-07 | $8.53M derived: sum of 2 quarters · filed 2023-11-07 | $9.10M derived: sum of 3 quarters · filed 2023-11-07 | $15.62M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $5.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $5.92M derived: sum of 2 quarters · filed 2023-09-12 | $12.44M derived: sum of 3 quarters · filed 2023-09-12 | $9.51M 10-K · filed 2023-09-12 |
| 2022-03-31 | $568.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-09 | $7.09M derived: sum of 2 quarters · filed 2023-05-09 | $4.16M 10-Q · filed 2023-05-09 | -$3.12M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $6.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $3.59M 10-Q · filed 2023-02-07 | -$3.69M derived: sum of 3 quarters · filed 2023-02-07 | $1.88M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | -$2.93M 10-Q · filed 2022-11-08 | -$10.21M derived: sum of 2 quarters · filed 2022-11-08 | -$4.64M derived: sum of 3 quarters · filed 2022-11-08 | -$536.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$7.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | -$1.71M derived: sum of 2 quarters · filed 2022-09-13 | $2.39M derived: sum of 3 quarters · filed 2022-09-13 | -$5.88M 10-K · filed 2022-09-13 |
| 2021-03-31 | $5.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-10 | $9.67M derived: sum of 2 quarters · filed 2022-05-10 | $1.40M 10-Q · filed 2022-05-10 | -$4.33M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | -$4.17M 10-Q · filed 2022-02-09 | -$9.90M derived: sum of 3 quarters · filed 2022-02-09 | |
| 2020-09-30 | -$8.27M 10-Q · filed 2021-11-09 | -$14.00M derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-06-30 | -$5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $1.20M 10-K · filed 2021-09-23 | ||
| 2020-03-31 | $6.93M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |